Multiple sclerosis in Northern Ireland: A historical and global perspective

Ulster Medical Journal

Volumn 69, Issue 2, 2000, Pages 97-105

  McDonnell, G V ^a   Hawkins, S A ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; EPIDEMIC; FEMALE; FORECASTING; HISTORY; HUMAN; INFANT; IRELAND; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEWBORN; PRESCHOOL CHILD; PREVALENCE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; FORECASTING; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; INFANT; INFANT, NEWBORN; IRELAND; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 0034326518     PISSN: 00416193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Davenport C B. Multiple sclerosis from the standpoint of geographic distribution and race. Arch Neurol Psychiat 1922; 8: 51-60.
2. Bing R, Reese H. Die multiple sklerose in der Nordwest-Schweiz. Schweiz Med Wochsenschr 1926; 56: 30-34.
3. Allison R S. Disseminated sclerosis in North Wales, an inquiry into its incidence, frequency, distribution and other aetiological factors. Brain 1931; 53: 391-430.
4. Charcot J-M. Histologie de la sclérose en plaques. Gazette Hôpital, Paris 1868; 41: 554-555, 557-558, 566.
5. Charcot J-M. In: translated by George Sigerson, editor. Lectures on the Diseases of the Nervous System. London: The New Sydenham Society, 1877: 158-222.
6. Limburg C C. The geographic distribution of multiple sclerosis and its estimated prevalence in the United States. Proc Assoc Res Nerv Ment Dis 1950; 28: 15-24.
7. Hammond S R, de Wytt C, Maxwell I C et al. The epidemiology of multiple sclerosis in Queensland, Australia. J Neurol Sci 1987; 80: 185-204.
8. Hammond S R, McLeod J G, Millingen KS et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988; 111: 1-25.
9. Dean G. Annual incidence, prevalence and mortality of multiple sclerosis in white South African-born and in white immigrants to South Africa. Br Med J 1967; 2: 724-30.
10. Dean G, Kurtzke J F. On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J 1971; 3: 725-9.
11. Bulman D E, Ebers GC. The geography of MS reflects genetic susceptibility. J Trop Geograph Neurol 1992; 2: 66-72.
12. Kurtzke J F, Hyllested K. Multiple sclerosis in the Faroe Islands. III an alternative assessment of the three epidemics. Acta Neurol Scand 1987; 76: 317-39.
13. Kurtzke J F, Gudmundsson K R, Bergmann S. Multiple sclerosis in Iceland: 1. evidence of a postwar epidemic. Neurology 1982; 32: 143-50.
14. Sheremata W A, Poskanzer D C, Withum D G, MacLeod C L, Whiteside M E. Unusual occurrence on a tropical island of multiple sclerosis. Lancet 1985; 2: 618.
15. Ruse T, Grønning M, KlauberM R, Barrett-Connor E, Nyland H, Albrektsen G. Clustering of residence of multiple sclerosis patients at age 13-20 years in Hordaland, Norway. Am J Epidemiol 1991; 133: 932-9.
16. Haahr S, Munch M, Christensen T, Møller-Larsen A, Hvas J. Cluster of multiple sclerosis patients from Danish community. Lancet 1997; 349: 923.
17. Poskanzer D C, Walker A M, Yonkondy J, Sheridan J L. Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 1976; 26, Suppl 2: 14-17.
18. Cook S D, Cromarty J I, Tapp W, Poskanzer D, Walker J D, Dowling P C. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985; 35: 545-51.
19. Cook S D, MacDonald J, Tapp W, Poskanzer D, Dowling P C. Multiple sclerosis in the Shetland Islands: an update. Acta Neurol Scand 1988; 77: 148-51.
20. Phadke J G, Downie A W. Epidemiology of multiple sclerosis in the north-east (Grampian Region) of Scotland-an update. J Epidemiol Comm Hlth 1987; 41: 5-13.
21. Sharpe G, Price S E, Last A, Thompson R J. Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey. J Neurol Neurosurg Psychiatry 1995; 58: 22-6.
22. Rice-Oxley M, Williams E S, Rees J E. A prevalence survey of multiple sclerosis in Sussex. J Neurol Neurosurg Psychiatry 1995; 58: 27-30.
23. Robertson N, Deans J, Fraser M, Compston D A S. Multiple sclerosis in the north Cambridgeshire districts of East Anglia. J Neurol Neurosurg Psychiatry 1995; 59: 71-6.
24. Hennessy A, Swingler R J, Compston D A S. The incidence and mortality of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1989; 52: 1085-9.
25. Shepherd D I, Summers A. Prevalence of multiple sclerosis in Rochdale. J Neurol Neurosurg Psychiatry 1996; 61: 415-7.
26. Rothwell P M, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998; 64: 730-5.
27. Forbes R B, Wilson S V, Swingler R J. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist? J Neurol 1999; 246: 1033-1040.
28. Allison R S, Millar J H D. Prevalence of disseminated sclerosis in Northern Ireland. Ulster Med J 1954; 23 (suppl 2): 5-27.
29. Millar J H D. Multiple sclerosis in Northern Ireland. In: Rose F C, editor. Clinical Neuroepidemiology. Tunbridge Wells: Pitman Medical, 1980: 222-7.
30. Hawkins S A, Kee F. Updated epidemiological studies of multiple sclerosis in Northern Ireland. J Neurol 1988; 235 (suppl): S86.
31. Poser C M, Paty D W, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-3 1.
32. Kurtzke J F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
33. Brady R, Secerbegovic S, Dean G, Secerbegovic A-M. Multiple sclerosis in the Republic of Ireland. J Ir Med Assoc 1977; 70: 500-6.
34. Hutchinson M. Disability due to multiple sclerosis: a community-based study of an Irish county. Ir Med J 1986; 79: 48-50.
35. McDonnell G V, Hawkins S A. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 1998; 50: 423-8.
36. Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995; 58: 2-6.
37. Swingler R J, Compston D A S. The prevalence of multiple sclerosis in south-east Wales. J Neurol Neurosurg Psychiatry 1988; 51: 1520-4.
38. Lockyer M J. Prevalence of multiple sclerosis in five rural Suffolk practices. Br Med J 1991, 303: 347-8.
39. Williams E S, McKeran R O. Prevalence of multiple sclerosis in a south London borough. Br Med J 1986; 293: 237-9.
40. McDonnell G V, Hawkins S A. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1999; 66: 411.
41. Mumford C J, Fraser M B, Wood N W, Compston D A S. Multiple sclerosis in the Cambridge health district of East Anglia. J Neurol Neurosurg Psychiatry 1992; 55: 877-82.
42. The IFNß Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. 1. Clinical results of a multicenter, randomised, double-blind, placebo-controlled trial. Neurology 1993; 43: 655-61.
43. Johnson K P, Brooks B R, Cohen J A et al. Copolymer I reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 1995; 45: 1268-76.